Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

53 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q2 2020.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.3M shares of 266M outstanding shares and own 5.37% of the company stock.
Largest 10 shareholders include Capital World Investors (2.96M shares), Polygon Management Ltd. (2.15M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.79M shares), Capital International Investors (1.22M shares), MILLENNIUM MANAGEMENT LLC (727K shares), Alphabet Inc. (698K shares), CITADEL ADVISORS LLC (579K shares), FRANKLIN RESOURCES INC (545K shares), BAKER BROS. ADVISORS LP (486K shares), and Cormorant Asset Management, LP (480K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.